Caxton Corp as of March 31, 2018
Portfolio Holdings for Caxton Corp
Caxton Corp holds 23 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Strongbridge Bioph shs usd | 52.8 | $47M | 5.4M | 8.80 | |
Garrison Capital | 10.1 | $9.1M | 1.1M | 8.12 | |
Molecular Templates | 9.3 | $8.3M | 1.0M | 8.00 | |
Cm Fin | 7.4 | $6.6M | 810k | 8.20 | |
Agile Therapeutics | 5.2 | $4.7M | 1.8M | 2.57 | |
Scynexis | 4.4 | $4.0M | 3.0M | 1.34 | |
Berkshire Hathaway (BRK.B) | 2.1 | $1.9M | 9.3k | 199.53 | |
Jbg Smith Properties (JBGS) | 1.6 | $1.4M | 41k | 33.71 | |
PG&E Corporation (PCG) | 1.1 | $988k | 23k | 43.91 | |
Amer (UHAL) | 1.0 | $932k | 2.7k | 345.19 | |
Gtx Inc Del | 1.0 | $877k | 49k | 17.76 | |
Triangle Capital Corporation | 0.6 | $543k | 49k | 11.12 | |
Fs Investment Corporation | 0.6 | $508k | 70k | 7.25 | |
Anheuser-Busch InBev NV (BUD) | 0.5 | $486k | 4.4k | 109.83 | |
Alcentra Cap | 0.5 | $446k | 64k | 6.95 | |
Intec Pharma | 0.4 | $395k | 64k | 6.14 | |
Aclaris Therapeutics (ACRS) | 0.4 | $370k | 21k | 17.50 | |
Madrigal Pharmaceuticals (MDGL) | 0.3 | $233k | 2.0k | 116.56 | |
Adient (ADNT) | 0.3 | $229k | 3.8k | 59.67 | |
Dicerna Pharmaceuticals | 0.1 | $125k | 13k | 9.56 | |
Marinus Pharmaceuticals | 0.1 | $102k | 27k | 3.80 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $86k | 36k | 2.38 | |
Sierra Oncology | 0.1 | $78k | 38k | 2.08 |